-
1 month ago | 
optometrytimes.com | Sherrol A. Reynolds |Jessica Steen |Ashley Wallace-Tucker |Dipl ABO |Jordana Joy
From February 14-17, ophthalmic and optometric professionals gathered at EnVision Summit 2025. Besides soaking up the Puerto Rican sun, ODs shared their expertise on keratoconus, myopia, glaucoma, and everything in between. The Eye Care Network sat down with OD Envision faculty members to hear their insights during the meeting. Sherrol Reynolds, OD, FAAO, weighed in on what she thinks will be the biggest innovations to come in eye care.
-
Nov 21, 2024 | 
optometrytimes.com | Jessica Steen |Jordana Joy |Martin Harp
Jessica Steen, OD, FAAO, Dipl-ABO, emphasized the importance of ophthalmic therapeutic management, communication with oncology teams, and effective referral networks to improve patient outcomes in her presentation "Optometry Alchemy: Turning Clinical Insights into Gold" at this year's American Academy of Optometry meeting. Steen highlighted the need for optometrists to understand disease processes, treatment options, and when to refer patients beyond their scope.
-
Oct 15, 2024 | 
reviewofoptometry.com | Jessica Steen
A 44-year-old man presented with a red, painful right eye with reduced vision, which began immediately upon waking that morning. He reported significant headache on the right side with radiating pain through his neck and back as a result of the ocular discomfort. He had established history of lattice corneal dystrophy and reported a similar experience in his left eye two years prior. Pinhole visual acuity was 20/200 OD and 20/60 OS.
-
Oct 14, 2024 | 
healio.com | Kate Young |Heather Biele |Jessica Steen
Jessica Steen, OD, FAAO While the determination of medical necessity of an opioid prescription in any clinical setting is the result of a careful, individualized assessment and risk-benefit evaluation, the presented findings are a stark reminder of the potential impact of an opioid prescription on systemic health trajectory and the frequency of opioid prescribing. Here, 20% of the more than 1.5 million patients who underwent ophthalmic surgery included in analysis filled an opioid prescription.
-
Oct 9, 2024 | 
eyetube.net | Justin Schweitzer |Jessica Steen |Dipl ABO
The Pressure Is on: All Things Glaucoma Justin Schweitzer, OD, and Jessica Steen, OD, FAAO, Dipl ABO Show Description + Justin Schweitzer, OD, and Jessica Steen, OD, FAAO, Dipl ABO, delve into the glaucoma session. Dr. Steen underscores the critical role of early intervention in glaucoma treatment and the need to communicate patient goals effectively with the co-managing physician.
-
Sep 15, 2024 | 
reviewofoptometry.com | Jessica Steen
A 61-year-old woman presented for follow-up of primary open-angle glaucoma (POAG) with an ongoing report of feeling grittiness and tearing in both eyes. She has a history of bilateral trabeculectomy with mitomycin C with clinical failure in the left eye. She takes Vyzulta (latanoprostene bunod 0.024%, Bausch + Lomb), Rhopressa (netarsudil 0.02%, Alcon) and dorzolamide-timolol in the left eye only with on-label dosing and reported excellent adherence.
-
Apr 15, 2024 | 
reviewofoptometry.com | Jessica Steen
A 42-year-old woman with metastatic cervical cancer presented for baseline ophthalmic evaluation as referred by her oncologist prior to beginning a new systemic therapy, Tivdak (tisotumab vedotin, Seagen and Genmab). She reported mild fluctuating vision and occasional burning. Her best-corrected visual acuity (BCVA) was 20/20 OU with mild inferior corneal staining in each eye with unremarkable posterior segment.
-
Mar 17, 2024 | 
newsbreak.com | Jessica Steen
Welcome to NewsBreak, an open platform where diverse perspectives converge. Our contributor network of tens of thousands of creators appears alongside stories from established publications and journalists. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies.
-
Mar 17, 2024 | 
optometrytimes.com | Jessica Steen
At Vision Expo East 2024, Jessica Steen, OD, FAAO, delves into systemic medications that are associated with ocular adverse effects, ranging from benign to vision-threatening. Optometrists are often the first to encounter ocular adverse effects from systemic medication, and Steen offers insight into when to raise the issue with the prescribing doctor. Video transcriptHi I'm Dr. Jessica Steen. And we are in New York at Vision Expo East and I am here from an educational perspective.
-
Mar 15, 2024 | 
healio.com | Jessica Steen |Nancy Hemphill |Heather Biele
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW YORK — Optometrists may be the first to recognize adverse effects of systemic medications, which warrants collaboration with the prescribing physician, Jessica Steen, OD, FAAO, DiplABO, said at Vision Expo East.
